Company & Sponsor Intelligence

Hospital Universitari Vall d'Hebron Research Institute

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials4

Recruiting0

Completed2

Countries1

Therapeutic footprint

dementia_otherother_neurologyparkinsonsstroke

Indexed studies

NCT03602924Long-term Safety and Effectiveness of Levodopa-carbidopa Intestinal Gel Infusion
parkinsons · SpainUNKNOWN

NCT04593225Effectiveness of VIRTUAL SFCAMINA STUDY
other_neurology · SpainNA

NCT01073007Stroke Treatment With Acute Reperfusion and Simvastatin
stroke · SpainPHASE4

NCT04281186Retinal and Cognitive Dysfunction in Type 2 Diabetes
dementia_other · SpainCOMPLETED

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →